Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 08, 2024 11:31 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 8 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
May 08, 2024 06:30 ET
|
Veru Inc.
--Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific...
Anti-Obesity Drugs Global Strategic Business Report 2024: Market to Reach $4.8 Billion by 2030 - Saxenda Commands the AOM Market, Newer Drugs to Provide Impetus to Market Growth
May 07, 2024 10:41 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Anti-Obesity Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Anti-Obesity Drugs Market to...
Novo Nordisk A/S - share repurchase programme
May 06, 2024 14:44 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
May 06, 2024 14:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 03, 2024 13:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk A/S - share repurchase programme
May 01, 2024 08:30 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
April 26, 2024 06:16 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
Novo Nordisk A/S - Articles of Association, April 2024
April 24, 2024 08:57 ET
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association, April 2024
Attachment
Articles of Association 24 Apr 2024
...
Novo Nordisk A/S – Reduction of the share capital
April 24, 2024 08:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by...